过去一度认为门静脉癌栓系肝癌经导管动脉化疗栓塞（tran-scatheter arterial chemoembolization，TACE）的禁忌证，现在比较普遍认为，只有在门静脉主干完全栓塞而又无明显侧支循环形成时才属肝癌栓塞化疗的禁忌证...
基于8个网页-相关网页
...大以及肿瘤高发或者归并肝硬变而没有办法切除缝合切掉［1］经导管动脉化疗栓塞（transcatheterarterialchemoembolization,TACE）是今朝公认的对不克不及切除缝合切掉的PHC首选疗治要领之一此疗法在导致肝癌社团坏死以及病灶由大变小征...
基于6个网页-相关网页
经导管动脉化疗栓塞术 Transcatheter arterial chemoembolization ; t ransarterial chemoembolization
经导管肝动脉化疗栓塞 transcatheter arterial chemoembolization ; transcatheter hepatic arterial chemoembolization ; transcatheterhepaticarterialchemo embolization TACE ; transhepatic arterial chemoembolization
经导管肝动脉栓塞化疗 transcatheter arterial chemoembolization ; transcatheter arterial embotization ; TAE
经导管动脉栓塞化疗 transcatheter arterial chemoembolization ; TACE
经动脉导管栓塞化疗 transcatheter arterial chemembolization ; TACE
经导管动脉内化疗栓塞 transcatheter arterial chemoembolization
经肝动脉导管栓塞化疗 transhepatic arterial chemo embolization
目的：探讨肝恶性肿瘤经导管动脉化疗栓塞术(TACE)后出现缺血性并发症的频次、治疗方法和预后。
Purpose: To evaluate the frequency, methods of treatment, and the outcome of ischemic complications after transcatheter arterial chemoembolization (TACE) in hepatic malignant tumors.
目的探讨原发性肝癌经导管动脉栓塞化疗(TACE)术后的预后评估。
Objective To explore the prognostic evaluation of primary liver cancer after transcatheter arterial chemoembolization (TACE) operation.
目的分析经导管肝动脉化疗栓塞术(TACE)及部分脾栓塞术(PSE)联合治疗对原发性肝癌(HCC)患者的肝功能影响。
Objective to evaluate the effect of transcatheter arterial chemoembolization (TACE) plus partial spleen embolization (PSE) on the liver function in patients with hepatocellular carcinoma (HCC).
应用推荐